Yangzhou Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is VIBEGRON, with a corresponding US DMF Number 40068.
Remarkably, this DMF maintains an Active status since its submission on July 14, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 16, 2024, and payment made on July 19, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II